Tissue Framework Implementation Awaits Input From FDA Commissioner
This article was originally published in The Gray Sheet
Executive Summary
The Center for Biologics Evaluation & Research expects to brief FDA Commissioner Mark McClellan on the agency's three-part tissue framework in the next several weeks